Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARα-mediated increase of type II transglutaminase

Blood

Volumn 87, Issue 5, 1996, Pages 1939-1950

  Benedetti, Laura ^b   Grignani, Francesco ^b   Scicchitano, Bianca M ^b   Jetten, Anton M ^b   Diverio, Daniela ^b   Lo Coco, Francesco ^b   Avvisati, Giuseppe ^b   Gambacorti Passerini, Carlo ^b   Adamo, Sergio ^b   Levin, Arthur A ^b   Pelicci, Pier Giuseppe ^b   Nervi, Clara ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; 6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; CD18 ANTIGEN; ISOENZYME; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RETINOIC ACID DERIVATIVE; RETINOIC ACID RECEPTOR; RETINOID; RO 41 5253; RO 47 2077; SRI 11217; UNCLASSIFIED DRUG;

ACUTE MYELOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 13344260002     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.5.1939.bloodjournal8751939     Document Type: Article

References (65)

1. Pandolfi PP, Alcalay M, Mencarelli A, Biondi A, Lo Coco F, Grignani F, Pelicci PG: Structure and origin of the acute promyelocytic leukemia myl/RARA cDNAand characterization of its retinoid-binding and transactivation properties. Oncogene 6:1285, 1991
2. de Thé H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A: The PML-RARα fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675, 1991
3. Kakizuka A, Miller WH, Umesono K, Warrell RP, Frankel SR, Murty VVVS, Dmitrovsky E, Evans RM: Chromosomal translocation t(15; 17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell 66:663, 1991
4. Kastner P, Ferez A, Lutz Y, Rochette-Egly C, Gaub MP, Durand B, Lanotte M, Berger R, Chambon P: Structure, localization and transcriptional properties of two classes of retinoic acid receptor α fusion proteins in acute promyelocytic leukemia (APL): Structural similarities with a new family of oncoproteins. EMBO J 11:629, 1992
5. Chen Z, Brand NJ, Chen A, Chen S-J, Tong JH, Wang Z-Y, Waxman S, Zelent A: Fusion between a novel Kruppel-like zinc finger gene and retinoic acid receptor-α locus due to a variant t(11; 17) translocation associated with acute promyelocytic leukemia. EMBO J 12:1161, 1993
6. Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ: The t(5; 17) translocation in acute promyelocytic leukemia generates a nucleophosmin-RARα fusion transcript. Blood 84:1486a, 1994 (abstr, suppl 1)
7. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M Mencarelli A, Peschle C, Nicoletti I, Pelicci PG: The acute promyelocytic leukaemia specific PML/RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74-423, 1993
8. Rousselot P, Hardas B, Patel A, Guidez F, Gaken J, Castaigne S, Dejean A, de Thé H, Degos L, Farzaneh F, Chomienne C: The PML-RARα gene product of the (15; 17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells. Oncogene 9:545, 1994
9. Warrel RPJ, de Thé H, Wang ZY, Degos L: Acute promyelocytic leukemia. N Engl J Med 329:177, 1993
10. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Grignani F, Lo Coco F, Pelicci PG: Acute promyelocytic leukemia, from genetics to treatment. Blood 83:10, 1994
11. Degos L, Dombret H, Chomienne C, Daniel MT, Micléa JM, Chastang C, Castaigne S, Fenaux P: All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood 85:2643, 1995
12. Sporn MB, Roberts AB, Goodman DS: The Retinoids: Biology, Chemistry and Medicine. New York, NY, Raven, 1994
13. Blomhoff R: Vitamin A in Health and Disease. New York, NY, Dekker, 1994
14. Allenby G, Bocquel T, Saunders M, Kazmer S, Speck J, Rosenberger M, Lovey A, Kastner P, Grippo JF, Chambon P, Levin AA. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci USA 90:30, 1993
15. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C: 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68:397, 1992
16. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowsky T, Huselton C, Allenby G, Speck J, Kratzeisen C, Rosenberger M, Lovey A, Grippo JF: 9-cis retinoic acid stereotsomer binds and activates the nuclear receptor RXRa. Nature 355:359, 1992
17. Mangelsdorf DJ, Umesono K, Evans RM: The retinoid receptors, in Sporn MB, Roberts AB, Goodman DS (eds): The Retinoids: Biology, Chemistry, and Medicine. New York, NY, Raven, 1994, p 319
18. Kastner P, Chambon P: Role of nuclear retinoid receptors in the regulation of gene expression, in Blomhoff R (ed): Vitamin A in Health and Disease. New York, NY, Dekker, 1994, p 189
19. Lehmann JM, Jong L, Fanjul A, Cameron JF, Ping L, Haefner P, Dawson MI, Pfahl M: Retinoids selective for retinoid X receptor response pathways. Science 258:1944, 1992
20. Zhang X-K, Lehmann J, Hoffmann B, Dawson MI, Cameron J, Grauper G, Hermann T, Tran P, Pfahl M: Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature 358:587, 1992
21. Dawson MI, Elstner E, Kizaki M, Chen DL, Pakkala S, Keiner B, Koeffler HP: Myeloid differentiation mediated through retinoic acid receptor/retmoic X receptor (RXR) not RXR/RXR pathway. Blood 84:446, 1994
22. Nervi C, Poindexter EC, Grignani F, Pandolfi PP, Lo Coco F, Avvisati G, Pelicci PG, Jetten AM: Characterization of the PML-RARα chimeric product of the acute promyelocytic leukemia specific t(15; 17) translocation. Cancer Res 52:3687, 1992
23. Perez A, Kastner P, Sethi S, Lutz Y, Reibel C, Chambon P: PMLRAR homodimers: Distinct DNA binding properties and heterodimeric interactions with RXR. EMBO J 12:3171, 1993
24. Weis K, Rambaud S, Lavau C, Jansen J, Carvalho T, Carmo-Fonseca M, Lamond A, Dejean A: Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell 76:345, 1994
25. Dyck JA, Maul GG, Miller WH, Chen JD, Kakizuka A, Evans RM: A novel macromolecular structure is a target of the promyelocyte-retmoic acid receptor oncoprotein. Cell 76:333, 1994
26. Folk JE. Transglutaminases. Annu Rev Biochem 49:517, 1980
27. Ichinose A, Hendrickson LE, Fujikawa K, Davie DJ: Amino acid sequence of the subunit of human factor XIII. Biochemistry 25:6900, 1986
28. Floyd EE, Jetten AM; Regulation of type I (epidermal) transglutaminase mRNA levels during squamous differentiation: Down regulation by retinoids. Mol Cell Biol 9:4846, 1989
29. Chiocca EA, Davies PJA, Stein JP. Regulation of tissue transglutaminase gene expression as a molecular model for retinoid effects on proliferation and differentiation. J Cell Biochem 39:293, 1988
30. Davies PJA, Murtaugh MP, Moore WT, Johnson GS, Lucas D: Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia (HL-60). J Biol Chem 260:5166, 1985
31. Fesus L, Thomazy V, Falus A: Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett 224:104, 1987
32. Piacentini M, Davies PJA, Fesus L: Tissue transglutaminase in cells undergoing apoptosis, in Tomei LD, Cope FO (eds): Apoptosis II: The Molecular Basis of Apoptosis in Disease. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1994, p 143
33. Zhang LX, Mills KJ, Dawson MI, Collins SJ, Jetten AM: Evidence for the involvement of retinoic acid receptor RAR alpha-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids. J Biol Chem 270:6022, 1995
34. h: A GTP-binding protein with transglutaminase activity and receptor signaling function. Science 264:1593, 1994
35. Eitan S, Schwartz M: A transglutaminase that converts interleukin-2 into a factor cytotoxic to oligodendrocytes. Science 261:106, 1993
36. de Thé H, Chomienne C, Lanotte M, Degos L, Dejean A: The t(15; 17) translocation of acute promyelocytic leukemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature 347:558, 1990
37. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R: NB4, a maturation inducible cell line with t(15; 17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080, 1991
38. Dermine S, Grignani F, Clerici M, Nervi C, Sozzi G, Talamo GP, Marchesi E, Formelli F, Parmiani G, Pelicci PG, Gambacorti-Passerini C: The occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the PML/RARα protein. Blood 82:1573, 1993
39. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Gallon DA, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103:620, 1985
40. Biondi A, Rambaldi A, Alcalay M, Pandolfi PP, Lo Coco F, Diverio D, Rossi V, Mencarelli A, Longo L, Zangrilli D, Masera G, Barbui T, Mandelli F, Grignani F, Pelicci PG: RARα rearrangements as genetic markers for diagnosis and monitoring in acute promyelocytic leukemia. Blood 77:1418, 1991
41. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM: Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345:224, 1990
42. Martin B, Bernardon JM, Cavey MT, Bernard BA, Carlavan I, Charpentier B, Pilgrim WR, Shroot B, Reichert U: Selective synthetic ligands for human nuclear retinoic acid receptors. Skin Pharmacol 5:57, 1992
43. Apfel C, Bauer F, Crettaz M, Forni L, Kamber M, Kaufmann F, LeMotte P, Pirson W, Klaus M: A retinoic acid receptor α antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci USA 89:7129, 1992
44. Delia D, Aiello A, Lombardi L, Pelicci PG, Grignani F, Grignani F, Formelli F, Menard S, Costa A, Veronesi U, Pierotti MA: N-(4-Hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Cancer Res 53:6036, 1993
45. Ochs H, Igo I: The NBT slide test: A simple screening method for detecting chronic granulomatous disease and female carriers. J Pediatr 83:444, 1973
46. Nervi C, Grippo JF, Sherman MI, George MD, Jetten AM: Identification and characterization of nuclear retinoic acid-binding activity in human myeloblastic leukemia HL-60 cells. Proc Natl Acad Sci USA 86:5854, 1989
47. Jetten AM, Grippo JF, Nervi C: Isolation and binding characteristics of nuclear retinoic acid receptors, in Packer L (ed): Methods in Enzymology, vol "Retinoids." San Diego, CA, Academic, 1990, p 248
48. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1989
49. Kishimoto TK, O'Connor K, Lee A, Roberts TM, Springer TA: Cloning of the β-subunit of the leukocyte adhesion proteins: Homology to an extracellular matrix receptor defines a novel supergene family. Cell 48:681, 1987
50. Dugaicyzk AD, Haron JA, Stone EM, Dennison OE, Rothblum KN, Schwartz RJ: Cloning and sequencing of a ribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle. Biochemistry 22:1605, 1983
51. Jetten AM, Shirley JE: Characterization of transglutaminase activity in rabbit tracheal epithelial cells. J Biol Chem 261:15097, 1986
52. Birckbichler PJ, Upchurch HF, Patterson MKJ, Conway E: A monoclonal antibody to cellular transglutaminase. Hybridoma 4:179, 1985
53. Robertson K, Emami B, Collins SJ: Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood 80:1885, 1992
54. Gianni M, Terao M, Zanotta S, Barbui T, Rambaldi A, Garattini E: Retinoic acid and granulocyte colony-stimulating factor synergistically induce leukocyte alcaline phosphatase in acute promyelocytic leukemia cells. Blood 83:1909, 1994
55. Nervi C, Vollberg TM, Grippo JF, Lucas DA, George MD, Sherman MI, Shudo K, Jetten AM: Expression of nuclear retinoic acid receptors in wilde type and mutant embryonal carcinoma PCC4.aza1R cells. Cell Growth Differ 1:535, 1990
56. Delva L, Comic M, Balitrand N, Guidez F, Miclea JM, Delmer A, Teillet F, Fenaux P, Castaigne S, Degos L, Chomienne C: Resistance to all-trans retinoic acid therapy in relapsing acute promyelocytic leukemia: study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood 82:2175, 1993
57. Testa U, Grignani F, Barberi T, Fagioli M, Masciulli R, Ferrucci PF, Seripa D, Camagna A, Alcalay M, Pelicci PG, Peschle C: PML/RARa U937 mutant and NB4 cell lines: Retinoic acid restores the monocytic differentiation response to Vitamin D3. Cancer Res 54:4508, 1994
58. Avvisati G, Baccarani M, Ferrara F, Lazzarino M, Resegotti L, Mandelli F: AIDA protocol (all-trans-retinoic acid+Idarubicin) in the treatment of newly diagnosed acute promyelocytic leukemia (APL): Pilot study of the Italian Cooperative Group GIMEMA. Blood 84:380a, 1994 (abstr, suppl 1)
59. Davies PJA, Basilion JP, Chiocca EA, Johnson J, Podder S, Stein JP: Retinoids as generalized regulators of cellular growth and differentiation. Am J Med Sci 296:164, 1988
60. Suedhoff T, Birckbichler PJ, Lee KN, Conway E, Patterson MKJ: Differential expression of transglutaminase in human erythroleukemia cells in response to retinoic acid. Cancer Res 50:7830, 1990
61. Agura ED, Howard M, Collins SJ: Identification and sequence analysis of the promoter for the leukocyte integrin β-subunit (CD 18): A retinoic acid-inducible gene. Blood 79:602, 1992
62. Lu S, Saydak M, Gentile V, Stein JP, Davies PJA: Isolation and characterization of the human tissue transglutaminase gene promoter. J Biol Chem 270:9748, 1995
63. Fesus L, Davies PJA, Piacentini M: Apoptosis: Molecular mechanisms in programmed cell death. Eur J Cell Biol 56:170, 1991
64. Park JR, Robertson K, Hickstein DD, Schickwann T, Hockenbery DM, Collins SJ: Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. Blood 84:440, 1994
65. Naumovski L, Cleary ML: Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood 83:2261, 1994